Literature DB >> 26147533

Identification of a Vav2-dependent mechanism for GDNF/Ret control of mesolimbic DAT trafficking.

Shuyong Zhu1, Chengjiang Zhao2, Yingying Wu2, Qiaoqiao Yang3, Aiyun Shao1, Tiepeng Wang1, Jianfu Wu1, Yanqing Yin1, Yandong Li1, Jincan Hou1, Xinhua Zhang4, Guomin Zhou5, Xiaosong Gu6, Xiaomin Wang7, Xosé R Bustelo8, Jiawei Zhou1.   

Abstract

Dopamine (DA) homeostasis is essential for a variety of brain activities. Dopamine transporter (DAT)-mediated DA reuptake is one of the most critical mechanisms for normal DA homeostasis. However, the molecular mechanisms underlying the regulation of DAT activity in the brain remain poorly understood. Here we show that the Rho-family guanine nucleotide exchange factor protein Vav2 is required for DAT cell surface expression and transporter activity modulated by glial cell line-derived neurotrophic factor (GDNF) and its cognate receptor Ret. Mice deficient in either Vav2 or Ret displayed elevated DAT activity, which was accompanied by an increase in intracellular DA selectively in the nucleus accumbens. Vav2(-/-) mice exposed to cocaine showed reduced DAT activity and diminished behavioral cocaine response. Our data demonstrate that Vav2 is a determinant of DAT trafficking in vivo and contributes to the maintenance of DA homeostasis in limbic DA neuron terminals.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26147533     DOI: 10.1038/nn.4060

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  61 in total

1.  Membrane-targeting is critical for the phosphorylation of Vav2 by activated EGF receptor.

Authors:  P Tamás; Z Solti; L Buday
Journal:  Cell Signal       Date:  2001-07       Impact factor: 4.315

Review 2.  The GDNF family: signalling, biological functions and therapeutic value.

Authors:  Matti S Airaksinen; Mart Saarma
Journal:  Nat Rev Neurosci       Date:  2002-05       Impact factor: 34.870

3.  Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction.

Authors:  Vincent Sauzeau; María A Sevilla; Juan V Rivas-Elena; Enrique de Alava; María J Montero; José M López-Novoa; Xosé R Bustelo
Journal:  Nat Med       Date:  2006-06-11       Impact factor: 53.440

4.  Membrane trafficking regulates the activity of the human dopamine transporter.

Authors:  H E Melikian; K M Buckley
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

5.  Wound healing defect of Vav3-/- mice due to impaired {beta}2-integrin-dependent macrophage phagocytosis of apoptotic neutrophils.

Authors:  Anca Sindrilaru; Thorsten Peters; Jürgen Schymeinsky; Tsvetelina Oreshkova; Honglin Wang; Anne Gompf; Francesca Mannella; Meinhard Wlaschek; Cord Sunderkötter; Karl Lenhard Rudolph; Barbara Walzog; Xosé R Bustelo; Klaus D Fischer; Karin Scharffetter-Kochanek
Journal:  Blood       Date:  2009-01-15       Impact factor: 22.113

6.  Low and high cocaine locomotor responding male Sprague-Dawley rats differ in rapid cocaine-induced regulation of striatal dopamine transporter function.

Authors:  Bruce H Mandt; Nancy R Zahniser
Journal:  Neuropharmacology       Date:  2009-12-04       Impact factor: 5.250

7.  Cre-lox-regulated conditional RNA interference from transgenes.

Authors:  Andrea Ventura; Alexander Meissner; Christopher P Dillon; Michael McManus; Phillip A Sharp; Luk Van Parijs; Rudolf Jaenisch; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

8.  Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column.

Authors:  A Auricchio; M Hildinger; E O'Connor; G P Gao; J M Wilson
Journal:  Hum Gene Ther       Date:  2001-01-01       Impact factor: 5.695

9.  Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux.

Authors:  James D Foster; Jae-Won Yang; Amy E Moritz; Sathyavathi Challasivakanaka; Margaret A Smith; Marion Holy; Kyle Wilebski; Harald H Sitte; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

10.  Vav3-deficient mice exhibit a transient delay in cerebellar development.

Authors:  Celia Quevedo; Vincent Sauzeau; Mauricio Menacho-Márquez; Antonio Castro-Castro; Xosé R Bustelo
Journal:  Mol Biol Cell       Date:  2010-01-20       Impact factor: 4.138

View more
  19 in total

1.  The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters through a Rho-Dependent Mechanism.

Authors:  Daniel P Bermingham; J Andrew Hardaway; Osama Refai; Christian R Marks; Sam L Snider; Sarah M Sturgeon; William C Spencer; Roger J Colbran; David M Miller; Randy D Blakely
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

Review 2.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

3.  Allosteric Modulator KM822 Attenuates Behavioral Actions of Amphetamine in Caenorhabditis elegans through Interactions with the Dopamine Transporter DAT-1.

Authors:  Osama Refai; Shaili Aggarwal; Mary Hongying Cheng; Zayna Gichi; Joseph M Salvino; Ivet Bahar; Randy D Blakely; Ole V Mortensen
Journal:  Mol Pharmacol       Date:  2021-12-14       Impact factor: 4.436

4.  Dysregulation of iron homeostasis and methamphetamine reward behaviors in Clk1-deficient mice.

Authors:  Peng-Ju Yan; Zhao-Xiang Ren; Zhi-Feng Shi; Chun-Lei Wan; Chao-Jun Han; Liu-Shuai Zhu; Ning-Ning Li; John L Waddington; Xue-Chu Zhen
Journal:  Acta Pharmacol Sin       Date:  2021-11-22       Impact factor: 7.169

5.  GDNF and alcohol use disorder.

Authors:  Segev Barak; Somayeh Ahmadiantehrani; Marian L Logrip; Dorit Ron
Journal:  Addict Biol       Date:  2018-05-04       Impact factor: 4.280

6.  A Conserved GEF for Rho-Family GTPases Acts in an EGF Signaling Pathway to Promote Sleep-like Quiescence in Caenorhabditis elegans.

Authors:  Amanda L Fry; Jocelyn T Laboy; Huiyan Huang; Anne C Hart; Kenneth R Norman
Journal:  Genetics       Date:  2016-01-22       Impact factor: 4.562

Review 7.  In Situ Regulated Dopamine Transporter Trafficking: There's No Place Like Home.

Authors:  Rita R Fagan; Patrick J Kearney; Haley E Melikian
Journal:  Neurochem Res       Date:  2020-03-07       Impact factor: 3.996

Review 8.  The Non-Survival Effects of Glial Cell Line-Derived Neurotrophic Factor on Neural Cells.

Authors:  Daniel Cortés; Oscar A Carballo-Molina; María José Castellanos-Montiel; Iván Velasco
Journal:  Front Mol Neurosci       Date:  2017-08-22       Impact factor: 6.261

9.  Striatal dopamine neurotransmission: regulation of release and uptake.

Authors:  David Sulzer; Stephanie J Cragg; Margaret E Rice
Journal:  Basal Ganglia       Date:  2016-08

Review 10.  Glial Cell Line-Derived Neurotrophic Factor Family Ligands, Players at the Interface of Neuroinflammation and Neuroprotection: Focus Onto the Glia.

Authors:  Anastasiia Kotliarova; Yulia A Sidorova
Journal:  Front Cell Neurosci       Date:  2021-06-17       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.